HK1244180A1 - 突變受體以及它們在基於核受體的誘導型基因表達系統中的應用 - Google Patents

突變受體以及它們在基於核受體的誘導型基因表達系統中的應用

Info

Publication number
HK1244180A1
HK1244180A1 HK18103783.5A HK18103783A HK1244180A1 HK 1244180 A1 HK1244180 A1 HK 1244180A1 HK 18103783 A HK18103783 A HK 18103783A HK 1244180 A1 HK1244180 A1 HK 1244180A1
Authority
HK
Hong Kong
Prior art keywords
gene expression
expression system
nuclear receptor
inducible gene
mutant receptors
Prior art date
Application number
HK18103783.5A
Other languages
English (en)
Inventor
Reddy Palli Subba
Basavaraju Kumar Mohan
Original Assignee
Intrexon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intrexon Corp filed Critical Intrexon Corp
Publication of HK1244180A1 publication Critical patent/HK1244180A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom
HK18103783.5A 2004-04-30 2018-03-19 突變受體以及它們在基於核受體的誘導型基因表達系統中的應用 HK1244180A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56729404P 2004-04-30 2004-04-30
US60942404P 2004-09-13 2004-09-13
US11/118,855 US7935510B2 (en) 2004-04-30 2005-04-29 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system

Publications (1)

Publication Number Publication Date
HK1244180A1 true HK1244180A1 (zh) 2018-08-03

Family

ID=35320809

Family Applications (2)

Application Number Title Priority Date Filing Date
HK07101887.7A HK1094521A1 (zh) 2004-04-30 2007-02-16 突變體受體和它們在核受體為主的誘導基因表達系統中的用途
HK18103783.5A HK1244180A1 (zh) 2004-04-30 2018-03-19 突變受體以及它們在基於核受體的誘導型基因表達系統中的應用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK07101887.7A HK1094521A1 (zh) 2004-04-30 2007-02-16 突變體受體和它們在核受體為主的誘導基因表達系統中的用途

Country Status (14)

Country Link
US (6) US7935510B2 (zh)
EP (4) EP3219204B1 (zh)
JP (2) JP4950032B2 (zh)
KR (1) KR101005735B1 (zh)
CN (3) CN102776218B (zh)
AU (2) AU2005241051B2 (zh)
BR (2) BRPI0510498B1 (zh)
CA (2) CA2979456A1 (zh)
DK (3) DK2292088T3 (zh)
HK (2) HK1094521A1 (zh)
MX (1) MXPA06012594A (zh)
NZ (2) NZ581440A (zh)
RU (1) RU2539036C2 (zh)
WO (1) WO2005108617A2 (zh)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033600A1 (en) * 2001-03-21 2004-02-19 Palli Subba Reddy Ecdysone receptor-based inducible gene expression system
US8105825B2 (en) * 2000-10-03 2012-01-31 Intrexon Corporation Multiple inducible gene regulation system
PT1456346E (pt) 2001-02-20 2012-05-02 Intrexon Corp Novo sistema de expressão de genes induzido baseado no recetor de ecdisona / recetor x retinoide invertebrado
JP4328094B2 (ja) 2001-02-20 2009-09-09 イントレクソン・コーポレイション 新規置換突然変異体受容体および核受容体−ベースの誘導性遺伝子発現システムにおけるその使用
CA2438133C (en) 2001-02-20 2015-01-27 Rheogene, Inc. Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
MXPA03007492A (es) * 2001-02-20 2004-10-15 Rheogene Holdings Inc Receptores de retinoide x quimerico y su uso en un sistema de expresion de gen inducible basado en receptor de ecdisona novedoso.
US7177763B2 (en) * 2001-09-25 2007-02-13 Werner Keber Method and device for preventing unpermitted approach of airplanes to objects on the ground which are to be protected
MXPA04002808A (es) 2001-09-26 2005-06-06 Rheogene Holdings Inc Acidos nucleicos receptores de ecdisona de mosca blanca, polipeptidos, y sus usos.
CA2459827C (en) * 2001-09-26 2013-09-03 Subba Reddy Palli Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
US7304161B2 (en) * 2003-02-10 2007-12-04 Intrexon Corporation Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
US7456315B2 (en) 2003-02-28 2008-11-25 Intrexon Corporation Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US7935510B2 (en) 2004-04-30 2011-05-03 Intrexon Corporation Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
US7544838B2 (en) * 2005-01-21 2009-06-09 City Of Hope Ligands for estrogen related receptors and methods for synthesis of said ligands
PT2043662E (pt) 2006-07-26 2015-11-25 Intrexon Corp Métodos e composições para tratamento de doença
MX363066B (es) 2007-05-29 2019-03-07 Intrexon Corp Ligandos quirales de diacilhidrazina para modular la expresion de genes exogenos por medio de un complejo receptor de ecdisona.
CA2698212A1 (en) * 2007-08-23 2009-02-26 Intrexon Corporation Methods and compositions for diagnosing disease
CN101848990B (zh) 2007-09-17 2013-07-31 罗门哈斯公司 改变植物生理学反应的组合物和方法
BRPI0817233A2 (pt) 2007-09-28 2012-11-06 Intrexon Corp construções terapêuticas de gene de trca e bireatores para a expressão de moléculas bioterapêuticas, e usos das mesmas
BRPI0818287A2 (pt) 2007-10-08 2015-11-03 Intrexon Corp células dendríticas manipuladas e usos para o tratamento do câncer.
JP5511144B2 (ja) * 2008-02-12 2014-06-04 学校法人福岡大学 てんかんモデル非ヒト哺乳動物
RU2487134C2 (ru) 2008-03-14 2013-07-10 Интрексон Корпорейшн Стероидные лиганды и их применение для модуляции переключения генов
CA2752697A1 (en) 2009-03-05 2010-09-10 Rohm And Haas Company Control of targeted turnover of key ethylene hormone signaling pathway proteins to modulate ethylene sensitivity in plants
EP3284821B1 (en) 2010-03-23 2022-01-05 Precigen, Inc. Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
EP2681327B1 (en) 2011-03-04 2018-11-21 Intrexon Corporation Vectors conditionally expressing protein
EP2699688A1 (en) 2011-04-20 2014-02-26 The Trustees Of The University Of Pennsylvania Regimens and compositions for aav-mediated passive immunization of airborne pathogens
MX350158B (es) 2011-09-08 2017-08-28 Intrexon Corp Diacilhidrazina cristalina y sus usos.
US9127024B2 (en) 2013-03-15 2015-09-08 Intrexon Corporation Boron-containing diacylhydrazines
US9719106B2 (en) 2013-04-29 2017-08-01 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
CA2918452A1 (en) 2013-07-15 2015-01-22 Donald Danforth Plant Science Center Enhanced oil production and stress tolerance in plants
US9723109B2 (en) * 2014-05-28 2017-08-01 Alexander Hertel Platform for constructing and consuming realm and object feature clouds
EP3194359B1 (en) 2014-09-17 2020-04-08 Intrexon Corporation Boron-containing diacylhydrazine compounds
EA201791289A1 (ru) 2014-12-11 2017-12-29 Президент Энд Феллоуз Оф Гарвард Колледж Ингибиторы клеточного некроза и связанные с ними способы
US11535665B2 (en) 2015-05-13 2022-12-27 The Trustees Of The University Of Pennsylvania AAV-mediated expression of anti-influenza antibodies and methods of use thereof
US20190062394A1 (en) 2015-10-10 2019-02-28 Intrexon Corporation Improved Therapeutic Control of Proteolytically Sensitive, Destabilized Forms of Interleukin-12
MA43404A (fr) 2015-11-11 2018-10-17 Intrexon Corp Compositions et procédés d'expression de multiples polypeptides biologiquement actifs à partir d'un seul vecteur pour le traitement d'affections et autres pathologies cardiaques
KR102469703B1 (ko) 2016-06-08 2022-11-23 프레시전 인코포레이티드 Cd33 특이적 키메라 항원 수용체
UY37343A (es) 2016-07-25 2018-02-28 Intrexon Corp Control del fenotipo en plantas
MX2019005235A (es) 2016-11-09 2019-12-05 Intrexon Corp Constructos de expresion de frataxina.
JP7091357B2 (ja) * 2016-12-12 2022-06-27 シアトル チルドレンズ ホスピタル （ディービーエイ シアトル チルドレンズ リサーチ インスティテュート） 哺乳動物細胞における薬物リガンドの誘導による導入遺伝子の発現に対する感受性が増強されたキメラ転写因子バリアント
US11692194B2 (en) 2017-01-10 2023-07-04 Precigen, Inc. Modulating expression of polypeptides via new gene switch expression systems
EP3589649A1 (en) 2017-02-28 2020-01-08 The Trustees Of The University Of Pennsylvania Influenza vaccines based on aav vectors
JOP20190200A1 (ar) 2017-02-28 2019-08-27 Univ Pennsylvania تركيبات نافعة في معالجة ضمور العضل النخاعي
US11827906B2 (en) 2017-02-28 2023-11-28 The Trustees Of The University Of Pennsylvania Adeno-associated virus (AAV) clade f vector and uses therefor
AU2018281316A1 (en) 2017-06-07 2020-01-02 Precigen, Inc. Expression of novel cell tags
SG11202008508QA (en) 2018-03-06 2020-10-29 Precigen Inc Hepatitis b vaccines and uses of the same
WO2020206056A1 (en) 2019-04-04 2020-10-08 Greenvenus Llc Peptides and methods of plant protection
US20210010006A1 (en) * 2019-07-08 2021-01-14 Inscripta, Inc. Increased nucleic acid-guided cell editing via a lexa-rad51 fusion protein
EP4061950A2 (en) * 2019-11-19 2022-09-28 Teknologian Tutkimuskeskus VTT OY Non-viral transcription activation domains and methods and uses related thereto
AU2021390480A1 (en) 2020-12-01 2023-06-22 The Trustees Of The University Of Pennsylvania Novel compositions with tissue-specific targeting motifs and compositions containing same
CA3216004A1 (en) 2021-04-23 2022-10-27 The Trustees Of The University Of Pennsylvania Novel compositions with brain-specific targeting motifs and compositions containing same
TW202325845A (zh) 2021-10-02 2023-07-01 賓州大學委員會 新穎aav衣殼及含其之組成物
WO2023147304A1 (en) 2022-01-25 2023-08-03 The Trustees Of The University Of Pennsylvania Aav capsids for improved heart transduction and detargeting of liver

Family Cites Families (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US229075A (en) * 1880-06-22 Railroad-switch signal
US1313276A (en) * 1919-08-19 Internal-combustion engine
US136447A (en) * 1873-03-04 Haeey ceoswell moeeis
US162780A (en) * 1875-05-04 Improvement in ox-bow pins
US1266015A (en) * 1916-09-21 1918-05-14 Bert Harrington Lock for motor-vehicles steering-wheels.
US4631211A (en) * 1985-03-25 1986-12-23 Scripps Clinic & Research Foundation Means for sequential solid phase organic synthesis and methods using the same
US4985461A (en) * 1985-10-21 1991-01-15 Rohm And Haas Company Insecticidal N'-substituted-N,N'-diacylhydrazines
US5117057A (en) * 1985-10-21 1992-05-26 Rohm And Haas Company Insecticidal N' substituted-N-N'-disubstituted-hydrazines
US5424333A (en) 1985-10-21 1995-06-13 Rohm And Haas Company Anthelmintic N'-substituted-N,N'-disubstitutedhydrazines
FR2593630B1 (fr) 1986-01-27 1988-03-18 Maurice Francois Ecran d'affichage a matrice active a resistance de drain et procedes de fabrication de cet ecran
US4859609A (en) * 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5225443A (en) * 1986-05-01 1993-07-06 Rohm And Haas Company Insecticidal N'-substituted-N'-substituted N,N'-diacylhydrazines
US5071773A (en) * 1986-10-24 1991-12-10 The Salk Institute For Biological Studies Hormone receptor-related bioassays
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US5171671A (en) * 1987-12-02 1992-12-15 The Salk Institute For Biological Studies Retinoic acid receptor composition
US5429952A (en) * 1988-02-02 1995-07-04 Biocode, Inc. Marking of products to establish identity and source
US5010175A (en) * 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
SG50681A1 (en) 1988-06-13 1998-07-20 American Biogenetic Sciences Method for the production of monoclonal antibodies utilizing a germfree animal
DK0463039T3 (da) 1989-03-15 1994-11-07 Hu Metal Eng Pty Ltd Apparat til formning af et rør fra en metalblikplade
US5354844A (en) 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US4954655A (en) * 1989-03-31 1990-09-04 Rohm And Haas Company Preparation of alkylhydrazines
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
AU654270B2 (en) * 1990-02-09 1994-11-03 Salk Institute For Biological Studies, The Retinoid receptor compositions and methods
WO1991013167A1 (en) * 1990-02-26 1991-09-05 The Board Of Trustees Of The Leland Stanford Junior University Identification and expression of insect steroid receptor dna sequences
US5641652A (en) * 1990-03-22 1997-06-24 The Salk Institute For Biological Studies Insect retinoid-like receptor compositions and methods
US7119077B1 (en) * 1990-03-22 2006-10-10 The Salk Institute For Biological Studies Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor
CA2075192A1 (en) * 1990-03-22 1991-09-23 Anthony E. Oro Insect retinoid receptor compositions and methods
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
CA2043775A1 (en) 1990-06-14 1991-12-15 Dat P. Le Dibenzoylakylcyanohydrazines
US5139749A (en) 1990-06-22 1992-08-18 Tas, Inc. Fluidized calcining process
IL100643A (en) * 1991-01-25 1996-10-31 Nippon Kayaku Kk History of hydrazine and pesticides containing these histories as an active ingredient
US5668175A (en) * 1991-08-23 1997-09-16 The Salk Institute For Biological Studies Use of selective ligands for treatment of disease states responsive to steroid or steroid-like retinoids
DE69232188T2 (de) * 1991-08-23 2002-06-20 Salk Inst For Biolog Studies L Verwendung von selektiven liganden zur behandlung von hormonansprechenden krankheitzuständen
WO1993006215A1 (en) * 1991-09-17 1993-04-01 The Salk Institute For Biological Studies Receptor of the thyroid/steroid hormone receptor superfamily
CA2121800A1 (en) * 1991-12-06 1993-06-10 Ronald M. Evans Multimeric forms of members of the steroid/thyroid superfamily of receptors
CA2106382A1 (en) * 1992-01-24 1993-07-25 Mark Leid Heterodimeric nuclear receptors proteins, genes encoding same, and usage thereof
US6013836A (en) * 1992-02-28 2000-01-11 Rohm And Haas Company Insecticidal N'-substituted-N,N'-disubstitutedhydrazines
US5530028A (en) * 1992-11-23 1996-06-25 Rohm And Haas Company Insecticidal N'-substituted-N,N'-diacylhydrazines
AU686186B2 (en) 1993-05-27 1998-02-05 Aventisub Ii Inc. Topologically segregated, encoded solid phase libraries
AU1173995A (en) * 1993-11-10 1995-05-29 Arch Development Corporation Ubiquitous nuclear receptor: compositions and methods
FR2714830B1 (fr) 1994-01-10 1996-03-22 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
FR2715847B1 (fr) 1994-02-08 1996-04-12 Rhone Poulenc Rorer Sa Composition contenant des acides nucléiques, préparation et utilisations.
US5423333A (en) * 1994-02-23 1995-06-13 Orthopedic Systems, Inc. Apparatus for shoulder immobilization
FR2727679B1 (fr) 1994-12-05 1997-01-03 Rhone Poulenc Rorer Sa Nouveaux agents de transfection et leurs applications pharmaceutiques
US6326166B1 (en) * 1995-12-29 2001-12-04 Massachusetts Institute Of Technology Chimeric DNA-binding proteins
CA2210248A1 (en) * 1995-01-13 1996-07-18 Ronald M. Evans Allosteric control of nuclear hormone receptors
FR2730637B1 (fr) 1995-02-17 1997-03-28 Rhone Poulenc Rorer Sa Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
ATE293699T1 (de) * 1995-03-03 2005-05-15 Syngenta Participations Ag Kontrolle der pflanzengenexpression durch rezeptor-vermittelte transaktivation in gegenwart von einem chemischen ligand
CZ372297A3 (cs) 1995-05-26 1998-03-18 Zeneca Limited Přepínání genové exprese využívající receptoru pro ekdyson
US5939442A (en) * 1995-06-07 1999-08-17 The Salk Institute For Biological Studies Modulations of peroxisome proliferator activated receptor-γ, and methods for the use thereof
US6266622B1 (en) 1995-12-13 2001-07-24 Regents Of The University Of California Nuclear receptor ligands and ligand binding domains
GB9606126D0 (en) 1996-03-22 1996-05-22 British Biotech Pharm Biosensors
CA2200423C (en) 1996-03-26 2006-12-19 Sietse Mosselman Novel estrogen receptor
CA2251466A1 (en) 1996-04-05 1997-10-16 The Salk Institute For Biological Studies Hormone-mediated methods for modulating expression of exogenous genes in mammalian systems, and products related thereto
US6723531B2 (en) * 1996-04-05 2004-04-20 The Salk Institute For Biological Studies Method for modulating expression of exogenous genes in mammalian systems, and products related thereto
US6610828B1 (en) * 1996-05-24 2003-08-26 Syngenta Limited Heliothis ecdysone receptor
US6025483A (en) * 1996-06-05 2000-02-15 The Regents Of The University Of California Maize and cauliflower apetalai gene products and nucleic acid molecules encoding same
US5919667A (en) * 1996-06-20 1999-07-06 The Salk Institute For Biological Studies Modular assembly retroviral vectors and uses thereof
US5942444A (en) 1997-01-27 1999-08-24 Biocode, Inc. Marking of products to establish identity, source and fate
WO1998035550A2 (en) 1997-02-14 1998-08-20 New Zealand Pastoral Agriculture Research Institute Limited Insect ecdysteroid receptors
US6300488B1 (en) * 1997-07-10 2001-10-09 The Salk Institute For Biological Studies Modified lepidopteran receptors and hybrid multifunctional proteins for use in transcription and regulation of transgene expression
AU738494B2 (en) 1997-07-10 2001-09-20 Salk Institute For Biological Studies, The Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression
WO1999010510A2 (en) 1997-08-26 1999-03-04 Ariad Gene Therapeutics, Inc. Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
US7101681B1 (en) 1997-11-21 2006-09-05 Amgen, Inc. Nuclear hormone receptor drug screens
US6756491B2 (en) * 1998-01-09 2004-06-29 The Salk Institute For Biological Studies Steroid-activated nuclear receptors and uses therefor
AUPP135698A0 (en) 1998-01-15 1998-02-05 Commonwealth Scientific And Industrial Research Organisation Insectical modalities
US6410245B1 (en) * 1998-04-01 2002-06-25 Affymax, Inc. Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
WO1999051777A2 (en) 1998-04-06 1999-10-14 Bunsen Rush Laboratories, Inc. Directed evolution biosensors
US6333318B1 (en) 1998-05-14 2001-12-25 The Salk Institute For Biological Studies Formulations useful for modulating expression of exogenous genes in mammalian systems, and products related thereto
US6258603B1 (en) 1998-06-17 2001-07-10 Rohm And Haas Company Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US6117639A (en) * 1998-08-31 2000-09-12 Vertex Pharmaceuticals Incorporated Fusion proteins, DNA molecules, vectors, and host cells useful for measuring protease activity
AR021484A1 (es) * 1998-09-10 2002-07-24 Pioneer Hi Bred Int Nuevos receptores de ecdisona y metodos de uso de los mismos
US5989863A (en) * 1998-10-14 1999-11-23 Incyte Pharmaceuticals, Inc. Human ankyrin family protein
WO2000071743A1 (fr) 1999-05-25 2000-11-30 Eisai Co., Ltd. Methode bihybride dans une cellule de mammifere
US6439706B1 (en) 1999-05-25 2002-08-27 Silverbrook Research Pty Ltd. Printer cartridge with binder
IL147295A0 (en) 1999-07-01 2002-08-14 Commw Scient Ind Res Org Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and uses therefor
US7057015B1 (en) 1999-10-20 2006-06-06 The Salk Institute For Biological Studies Hormone receptor functional dimers and methods of their use
EP1259537A4 (en) 2000-02-24 2004-05-12 Salk Inst For Biological Studi GENE EXPRESSION SYSTEM BASED ON CHIMERAL RECEPTORS
WO2001070816A2 (en) 2000-03-22 2001-09-27 Rohm And Haas Company Ecdysone receptor-based inducible gene expression system
US20040033600A1 (en) 2001-03-21 2004-02-19 Palli Subba Reddy Ecdysone receptor-based inducible gene expression system
US8105825B2 (en) 2000-10-03 2012-01-31 Intrexon Corporation Multiple inducible gene regulation system
JP4328094B2 (ja) * 2001-02-20 2009-09-09 イントレクソン・コーポレイション 新規置換突然変異体受容体および核受容体−ベースの誘導性遺伝子発現システムにおけるその使用
PT1456346E (pt) 2001-02-20 2012-05-02 Intrexon Corp Novo sistema de expressão de genes induzido baseado no recetor de ecdisona / recetor x retinoide invertebrado
CA2438133C (en) 2001-02-20 2015-01-27 Rheogene, Inc. Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
MXPA03007492A (es) * 2001-02-20 2004-10-15 Rheogene Holdings Inc Receptores de retinoide x quimerico y su uso en un sistema de expresion de gen inducible basado en receptor de ecdisona novedoso.
CN1161325C (zh) 2001-03-26 2004-08-11 江苏省农药研究所 作为杀虫剂的二酰基肼类化合物及制备此种化合物的中间体以及它们的制备方法
CA2442830C (en) * 2001-04-06 2009-09-08 Matsushita Electric Corporation Of America Agitator drive system for vacuum cleaner
US20040072254A1 (en) * 2001-05-01 2004-04-15 Senomyx, Inc. High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds
CA2459827C (en) 2001-09-26 2013-09-03 Subba Reddy Palli Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
MXPA04002808A (es) 2001-09-26 2005-06-06 Rheogene Holdings Inc Acidos nucleicos receptores de ecdisona de mosca blanca, polipeptidos, y sus usos.
US20050228016A1 (en) 2002-06-13 2005-10-13 Enrique Michelotti Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
US7375093B2 (en) 2002-07-05 2008-05-20 Intrexon Corporation Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US6942899B2 (en) * 2002-07-08 2005-09-13 The Boeing Company Coating for inhibiting oxidation of a substrate
US7048235B2 (en) * 2002-10-09 2006-05-23 The Boeing Company Slotted aircraft wing
US7304161B2 (en) 2003-02-10 2007-12-04 Intrexon Corporation Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
US7304162B2 (en) 2003-02-21 2007-12-04 Intrexon Corporation Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US7456315B2 (en) * 2003-02-28 2008-11-25 Intrexon Corporation Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
US7047453B2 (en) * 2003-11-13 2006-05-16 Nokia, Inc. Method and apparatus for managing network traffic using cyclical redundancy check hash functions
US7935510B2 (en) 2004-04-30 2011-05-03 Intrexon Corporation Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
KR100632185B1 (ko) * 2004-10-15 2006-10-11 한국전자통신연구원 광 통신 패킷 데이터 정합기능을 제공하는 홈 게이트웨이시스템 및 이를 이용한 댁내 방송서비스 제공 방법
US9034650B2 (en) 2005-02-02 2015-05-19 Intrexon Corporation Site-specific serine recombinases and methods of their use
JP5863489B2 (ja) * 2011-02-17 2016-02-16 キヤノン株式会社 インクジェット記録ヘッド、及び、記録装置

Also Published As

Publication number Publication date
NZ551657A (en) 2009-12-24
JP5385364B2 (ja) 2014-01-08
AU2010235975B2 (en) 2011-10-13
CN102776218B (zh) 2017-04-12
HK1094521A1 (zh) 2007-04-04
EP3000317A1 (en) 2016-03-30
CA2979456A1 (en) 2005-11-17
BRPI0510498A (pt) 2007-11-20
WO2005108617A3 (en) 2006-02-09
CN1964622B (zh) 2015-08-26
EP1744619B1 (en) 2015-10-21
DK2292088T3 (da) 2013-05-13
US20140322812A1 (en) 2014-10-30
EP3219204B1 (en) 2019-08-07
CA2563521C (en) 2017-09-19
US20170342440A1 (en) 2017-11-30
KR101005735B1 (ko) 2011-01-06
US20080145935A1 (en) 2008-06-19
DK3000317T3 (da) 2017-11-06
BRPI0510498B1 (pt) 2018-02-06
MXPA06012594A (es) 2006-12-15
EP1744619A2 (en) 2007-01-24
US9163256B2 (en) 2015-10-20
RU2011146202A (ru) 2013-05-20
AU2010235975A1 (en) 2010-11-11
US8076454B2 (en) 2011-12-13
CN105018509A (zh) 2015-11-04
EP2292088B1 (en) 2013-01-30
US20080216184A1 (en) 2008-09-04
US20120185954A1 (en) 2012-07-19
NZ581440A (en) 2012-03-30
JP2012045009A (ja) 2012-03-08
CA2563521A1 (en) 2005-11-17
JP4950032B2 (ja) 2012-06-13
CN1964622A (zh) 2007-05-16
JP2008505616A (ja) 2008-02-28
EP3000317B1 (en) 2017-07-12
BR122015016288B1 (pt) 2019-03-26
EP2292088A1 (en) 2011-03-09
US7935510B2 (en) 2011-05-03
WO2005108617A2 (en) 2005-11-17
CN105018509B (zh) 2019-03-05
KR20070016157A (ko) 2007-02-07
DK1744619T3 (en) 2016-01-25
US20050266457A1 (en) 2005-12-01
AU2005241051A1 (en) 2005-11-17
CN102776218A (zh) 2012-11-14
EP1744619A4 (en) 2007-09-26
AU2005241051B2 (en) 2010-07-22
EP3219204A1 (en) 2017-09-20
RU2539036C2 (ru) 2015-01-10

Similar Documents

Publication Publication Date Title
HK1244180A1 (zh) 突變受體以及它們在基於核受體的誘導型基因表達系統中的應用
EP1373470A4 (en) NOVEL RECEPTORS OF SUBSTITUTION MUTANTS AND USE THEREOF IN AN INDUCIBLE GENE EXPRESSION SYSTEM BASED ON NUCLEAR RECEPTORS
EP1534738A4 (en) NEW SUBSTITUTION MUTANT RECEPTORS AND THEIR USE IN AN INDUCIBLE GENE EXPRESSION SYSTEM BASED ON A NUCLEAR RECEPTOR
HK1162591A1 (en) Chimeric retinoid x receptors and their use in a novel ecdysone receptor- based inducible gene expression system
GB2435072B (en) Carabiner and connection tool for use with patient carrying systems
HK1112006A1 (en) Antibodies against il-13 receptor alpha 1 and uses thereof
EP1787185A4 (en) SYSTEMS AND METHODS FOR ENGAGING A PERSON TO INTERACTION WITH A COMPUTER PROGRAM WITH A GRAPHIC USER INTERFACE
EP1784740A4 (en) SYSTEM AND METHOD FOR MANAGING THE APPROVAL GIVEN BY A USER TO INVOICING IN A NETWORK ENVIRONMENT
IL181186A0 (en) Anti-fc-gamma riib receptor antibody and uses therefor
EP1908051A4 (en) SYSTEM AND METHOD FOR A THUMB-OPTIMIZED USER INTERFACE OF A TOUCH SCREEN
TWI347554B (en) Methods and apparatus for providing graphical indicators and inline controls for relating and managing portlets in a graphical user interface
EP1825424A4 (en) GRAPHIC USER INTERFACE USED WITH AN OPEN EXPERT SYSTEM
EP1835879A4 (en) DEVICE FOR SUPPORTING THE BODY WEIGHT AND PROGRAM FOR SUPPORTING THE BODY WEIGHT
ZA200504811B (en) User interface for providing task management and calendar information
SG155260A1 (en) Antibodies against human interleukin-13 and uses therefor
ZA200705674B (en) Peptides with neuropeptide-2 receptor (Y2R) agonist activity
IL179747A0 (en) Novel indazole carboxamides and their use
GB0508218D0 (en) Online thermal and watercut management
EP1989965A4 (en) METHOD AND DEVICE FOR HEATING CHAIR BY BATTERY CHARGE AND HEATING CHAIR OF TYPE BY BATTERY CHARGE
EP1917893A4 (en) TOILET SEATING DEVICE AND TOILET DEVICE THEREFOR
GB0625961D0 (en) Utilization-based fuel cell monitoring and control
IL197702A (en) Attach an antotype and use it as standard in a vaccine tester
GB2433324B (en) Laminate material testing methods and systems
HK1143416A1 (zh) 用於無炎症應激反應的指示劑及其用途
EP1796054A4 (en) FEE INFORMATION GENERATION DEVICE, FEED INFORMATION GENERATION PROGRAM, CONSIDERED INFORMATION GENERATION DEVICE, AND CONSIDERED INFORMATION GENERATION PROGRAM